Sagent Pharmaceuticals enters ophthalmic market, launches travoprost ophthalmic solution, USP 0.004%

Sagent Pharmaceuticals announced the launch of its travoprost ophthalmic solution, USP 0.004%, formally introducing the company into the ophthalmic market.

Travoprost is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

This will be the first product in Sagent’s ophthalmic portfolio, but the company states it plans to include other products in the “coming year.”

Vishy Chebrol, PhD, CEO of Sagent, commented on the launch in a press release from the company, saying, "Expanding into the ophthalmic space marks a significant step in broadening our portfolio and reinforcing our trajectory of sustainable growth. We remain guided by our mission to improve patient outcomes, while leveraging our proven strengths in quality and reliability to ensure dependable access and long-term value."

While this is the first in ophthalmology, the company boasts a portfolio of over 100 injectable and specialty pharmaceutical products for use in hospitals, long-term care facilities, alternate care sites, and clinics.

The company also notes its PreventIV Measures initiative, which includes packaging and labeling to help reduce the risk of medication errors in the pharmacy. The company accomplishes this by using consistently differentiated packaging and labeling across every level of packaging and labeling.

The company established this initiative because it says that generic injectable products from any one supplier tended to look alike, with similar labels and no differentiation to indicate different strengths or different drugs.

References:

1. Sagent Announces Launch of Travoprost Ophthalmic Solution, USP. Published September 15, 2025. Accessed September 16, 2025. https://www.prnewswire.com/news-releases/sagent-announces-launch-of-travoprost-ophthalmic-solution-usp-302555682.html

2. PreventIV Measures. Accessed September 16, 2025. https://www.preventivmeasures.com/